4//SEC Filing
Reynoso Jamie L. 4
Accession 0001801170-25-000240
CIK 0001801170other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 4:37 PM ET
Size
7.1 KB
Accession
0001801170-25-000240
Insider Transaction Report
Form 4
Reynoso Jamie L.
CEO, Medicare Advantage
Transactions
- Sale
Class A Common Stock
2025-10-07$2.65/sh−2,012$5,332→ 3,043,172 total - Tax Payment
Class A Common Stock
2025-10-03$2.59/sh−8,706$22,549→ 3,045,184 total
Footnotes (2)
- [F1]Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on October 3, 2025, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date.
- [F2]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. These shares were sold at a price of $2.65.
Documents
Issuer
CLOVER HEALTH INVESTMENTS, CORP. /DE
CIK 0001801170
Entity typeother
Related Parties
1- filerCIK 0001839066
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 4:37 PM ET
- Size
- 7.1 KB